Answers are grounded in this paper and cite their sources.
TLR4 deficiency protects against doxorubicin-induced cardiomyopathy in a mouse model.
TLR4 deficiency improves left ventricular function and attenuates pathophysiological key mechanisms in Dox-induced cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Riad et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: